François Gonzalvez

Chief Scientific Officer and Co-founder

A seasoned cancer biologist and drug discovery leader, he brings over 20 years of experience in oncology research, with a focus on precision medicine and translational science. Prior to Onco3R, François served as Vice President and Head of Oncology Discovery at Galapagos, where he built a portfolio of innovative small- and large-molecule therapies in precision oncology. His leadership helped shape a new era of targeted cancer therapies within the organization. He has previously held senior scientific roles at Aligos Therapeutics, Janssen Pharmaceutica (J&J Innovative Medicine), Ariad Pharmaceuticals, and Genentech. Over the course of his career, François has contributed to the discovery and development of multiple drug candidates, including precision medicines that have reached the market. François holds a Master’s degree and a PhD in Cancer Research and Molecular Pathology from the University of Glasgow. He also serves on the Scientific Advisory Board of Crown Bioscience, where he supports strategic initiatives in oncology and drug discovery.